Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When "Infarct" Isn't Infarct: A CT Perfusion Pitfall in Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Blood biomarker outliers and clinical events during intensive care in patients with traumatic brain injury.

Brain & spine·2026
Same author

Outlining the global variation in resources for traumatic brain injury care: site-level data from the Global Neurotrauma Outcomes Study (GNOS).

BMJ global health·2026
Same author

Consensus statement from the 2025 Delphi panel on cerebral microdialysis in critical care.

Critical care (London, England)·2026
Same author

Days alive and out of hospital after burr-hole drainage for chronic subdural haematoma: a national cohort study using Hospital Episode Statistics in England.

BMJ open·2026
Same author

Rapid versus gradual weaning of external ventricular drains in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Journal of neurosurgical sciences·2026
Same journal

Robotic platforms in neurosurgery: the great disappearing act.

British journal of neurosurgery·2026
Same journal

Morphological parameters contributing to aneurysm rupture: Identifying the rogue from the mugshot using different statistical methods.

British journal of neurosurgery·2026
Same journal

Does early surgical intervention for type II dens fractures improve survival in octogenarians? A propensity-matched analysis.

British journal of neurosurgery·2026
Same journal

A single-centre experience of fluoroscopic-guided erector spinae plane blocks in degenerative lumbar spine surgery.

British journal of neurosurgery·2026
Same journal

Lessons in resourcefulness: the SBNS Caribbean Training Fellowship.

British journal of neurosurgery·2026
Same journal

The effectiveness of indirect revascularization on haemorrhagic moyamoya disease and the activities that trigger intracranial haemorrhage: a comprehensive study.

British journal of neurosurgery·2026
See all related articles

Related Experiment Videos

What constitutes Clinical Equipoise?

Adel Helmy, Ivan Timofeev, Tom Santarius

    British Journal of Neurosurgery
    |September 1, 2009
    PubMed
    Summary
    This summary is machine-generated.

    Clinical Equipoise, a consensus on valid treatments, is superior to the Uncertainty Principle for ethical patient recruitment in neurosurgical randomized clinical trials. This distinction impacts trial outcomes and interpretation.

    Related Experiment Videos

    Area of Science:

    • Neurosurgery
    • Clinical Trials
    • Medical Ethics

    Background:

    • Ethical patient incorporation into randomized clinical trials (RCTs) relies on distinct principles.
    • Two key concepts are Clinical Equipoise and the Uncertainty Principle.

    Discussion:

    • Clinical Equipoise, representing a consensus on viable treatment options, offers a more robust ethical framework for neurosurgical RCT recruitment.
    • The Uncertainty Principle, reflecting individual clinician uncertainty, is less suitable for guiding trial recruitment.
    • The distinction between these principles significantly influences recruitment strategies and the interpretation of RCT results.

    Key Insights:

    • Clinical Equipoise is a superior ethical standard for neurosurgical RCT recruitment compared to the Uncertainty Principle.
    • The choice of ethical principle impacts patient recruitment and the validity of trial findings.
    • Understanding this distinction is crucial for advancing neurosurgical research.

    Outlook:

    • Further research should explore the practical implementation of Clinical Equipoise in diverse clinical trial settings.
    • Developing clear guidelines for assessing Clinical Equipoise can enhance ethical recruitment practices.
    • This ethical framework has the potential to improve the reliability and generalizability of neurosurgical trial outcomes.